Protara Therapeutics Files 2024 Annual Report
Ticker: TARA · Form: 10-K · Filed: Mar 5, 2025 · CIK: 1359931
| Field | Detail |
|---|---|
| Company | Protara Therapeutics, Inc. (TARA) |
| Form Type | 10-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, biotech, sec-filing
TL;DR
Protara Therapeutics filed its 2024 10-K. Check financials.
AI Summary
Protara Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, formerly known as ArTara Therapeutics, Inc. and Proteon Therapeutics Inc., is focused on biological products. Its principal executive offices are located at 345 Park Avenue South, 3rd Floor, New York, NY.
Why It Matters
This filing provides a comprehensive overview of Protara Therapeutics' financial performance and business operations for the past fiscal year, offering insights for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-36694 — SEC File Number (Identifies the company's filings with the SEC.)
- 20-4580525 — IRS Number (Company's Employer Identification Number.)
Key Players & Entities
- Protara Therapeutics, Inc. (company) — Registrant
- ArTara Therapeutics, Inc. (company) — Former company name
- Proteon Therapeutics Inc (company) — Former company name
- 345 Park Avenue South (location) — Principal executive office address
- 2024 (date) — Fiscal year end
FAQ
What is the primary business of Protara Therapeutics, Inc.?
Protara Therapeutics, Inc. is primarily involved in the business of biological products, as indicated by its Standard Industrial Classification code [2836].
When did Protara Therapeutics, Inc. change its name from ArTara Therapeutics, Inc.?
Protara Therapeutics, Inc. changed its name from ArTara Therapeutics, Inc. on January 10, 2020.
What is the filing date of this 10-K report?
This 10-K report was filed on March 5, 2025.
Where are Protara Therapeutics, Inc.'s principal executive offices located?
Protara Therapeutics, Inc.'s principal executive offices are located at 345 Park Avenue South, 3rd Floor, New York, NY 10010.
What is the SEC file number for Protara Therapeutics, Inc.?
The SEC file number for Protara Therapeutics, Inc. is 001-36694.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 5, 2025 regarding Protara Therapeutics, Inc. (TARA).